Rare gene defect may fuel liver cancer in otherwise healthy livers

NCT ID NCT07145385

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aims to find out how often a rare genetic condition called alpha-1 antitrypsin deficiency (AATD) occurs in people who develop liver cancer (hepatocellular carcinoma) but do not have cirrhosis or other known causes like hepatitis or heavy drinking. Researchers will look back at medical records of 71 adults with this type of liver cancer to see if AATD is a hidden risk factor. The results could help identify a new cause for some liver cancers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RETROSPECTIVE COHORT OF PATIENTS DIAGNOSED WITH HCC ON NON-CIRRHOTIC LIVER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Bordeaux

    Bordeaux, France